IMPACT OF ANTIFIBROTIC USE ON HEALTHCARE RESOURCE USE AND COST IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) IN A COMMERCIALLY INSURED PATIENT POPULATION

被引：1
|
作者：
Corral, Mitra
Deyoung, Kathryn
Kong, Amanda
机构：
来源：
CHEST | 2019年 / 156卷 / 04期
关键词：
D O I：
10.1016/j.chest.2019.08.1038
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
引用
收藏
页码：1137A / 1137A
页数：1
相关论文
共 50 条
  • [1] HEALTHCARE RESOURCE USE AND COST IN ANTIFIBROTIC-TREATED VS UNTREATED PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF) IN THE US MEDICARE POPULATION
    Corral, Mitra
    Chang, Eunice
    Broder, Michael
    Gokhale, Sohum
    Reddy, Sheila
    CHEST, 2020, 158 (04) : 1057A - 1057A
  • [2] PERSISTENCE AND ADHERENCE OF ANTIFIBROTIC MEDICATION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS IN A COMMERCIALLY INSURED PATIENT POPULATION
    Corral, Mitra
    DeYoung, Kathryn
    Kong, Amanda
    CHEST, 2019, 156 (04) : 437A - 437A
  • [3] HEALTHCARE RESOURCE USE AND COSTS IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS IN THE US MEDICARE POPULATION
    Reddy, Sheila
    Chang, Eunice
    Broder, Michael
    Gokhale, Sohum
    Corral, Mitra
    CHEST, 2019, 156 (04) : 440A - 441A
  • [4] Antifibrotic Drug Use in Patients with Idiopathic Pulmonary Fibrosis Data from the IPF-PRO Registry
    Salisbury, Margaret L.
    Conoscenti, Craig S.
    Culver, Daniel A.
    Yow, Eric
    Neely, Megan L.
    Bender, Shaun
    Hartmann, Nadine
    Palmer, Scott M.
    Leonard, Thomas B.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2020, 17 (11) : 1413 - 1423
  • [5] Effect of Antifibrotic Use on Mortality in Patients with Idiopathic Pulmonary Fibrosis
    Xu, Huiping
    Hui, Siu L.
    Lee, Joyce S.
    Zhang, Zuoyi
    Boente, Ryan D.
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2024, 21 (10) : 1407 - 1415
  • [6] COST OF OPIOID USE IN A COMMERCIALLY INSURED POPULATION OF FIBROMYALGIA PATIENTS
    Juday, T.
    Blum, S.
    Erder, M. H.
    VALUE IN HEALTH, 2009, 12 (03) : A134 - A135
  • [7] HEALTHCARE RESOURCE USE (HCRU) AND COSTS ASSOCIATED WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): A TARGETED LITERATURE REVIEW
    Coteur, G.
    Bastian, A.
    Clarke, D.
    Langley, J.
    VALUE IN HEALTH, 2020, 23 : S720 - S720
  • [8] Influence of Idiopathic Pulmonary Fibrosis Progression on Healthcare Resource Use
    Alex Diamantopoulos
    Toby M. Maher
    Nils Schoof
    Dirk Esser
    Corinne LeReun
    PharmacoEconomics - Open, 2019, 3 : 81 - 91
  • [9] Influence of Idiopathic Pulmonary Fibrosis Progression on Healthcare Resource Use
    Diamantopoulos, Alex
    Maher, Toby M.
    Schoof, Nils
    Esser, Dirk
    LeReun, Corinne
    PHARMACOECONOMICS-OPEN, 2019, 3 (01) : 81 - 91
  • [10] SWITCHING ANTIFIBROTIC MEDICATION IN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS (IPF): A DESCRIPTIVE STUDY
    Sun, Yihao
    Girard, Jennifer
    Dsouza, Kevin G.
    Luckhardt, Tracy
    Kulkarni, Tejaswini
    CHEST, 2023, 164 (04) : 3089A - 3090A
12345